Prescription drug · ANDA
Ramelteon NDC 42571-375
Ramelteon 8 mg/1 · Tablet · Oral · Micro Labs Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42571-375-01 | 4257103750142571037501 | 100 TABLET in 1 BOTTLE (42571-375-01)Marketed from May 1, 2023 | |
| 42571-375-05 | 4257103750542571037505 | 500 TABLET in 1 BOTTLE (42571-375-05)Marketed from May 1, 2023 | |
| 42571-375-30 | 4257103753042571037530 | 30 TABLET in 1 BOTTLE (42571-375-30)Marketed from May 1, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ramelteon
- Generic name (nonproprietary)
- ramelteon
- Active ingredients
- Ramelteon — 8 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Micro Labs LimitedNDC labeler code 42571
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215243
- Marketing start
- Listing expires
- Other FDA classes
- Melatonin Receptor Agonists (Mechanism)
- Identifiers
- Product ID 42571-375_336c8c9f-7af0-d608-e063-6394a90a5e21SPL ID 336c8c9f-7af0-d608-e063-6394a90a5e21SPL set ID 7545c79a-93ea-4f73-beb5-cac46b2ed7e9RxCUI 577348UNII 901AS54I69UPC 0342571375300
- Pharmacologic class
- Melatonin Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442571037501followed by a unit qualifier and the quantityPackage 42571-0375-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset. The clinical trials performed in support of efficacy were up to six months in duration. The final formal assessments of sleep latency were performed after two days of treatment during the crossover study (elderly only), at five weeks in the six week studies (adults and elderly), and at the end of the six month study (adults and elderly) [see Clinical Studies (14)]. Ramelteon tablet is indicated for the treatment of insomnia characterized by difficulty with sleep onset. (1)
Excerpt only. Read the full label for complete information.
About NDC 42571-375
- What is NDC 42571-375?
- 42571-375 is the product NDC for Ramelteon, Ramelteon 8 mg/1 tablet, listed with the FDA by Micro Labs Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ramelteon.
- What is the active ingredient?
- Ramelteon.
- Who is the labeler?
- Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ramelteon?
- 37 other product NDCs are listed under this name. See all Ramelteon NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ramelteon products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0593 | 80425-0593-01 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Marlex Pharmaceuticals, Inc. | 10135-838 | 10135-0838-0110135-0838-30 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | AvPAK | 50268-822 | 50268-0822-15 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 72162-2644 | 72162-2644-0172162-2644-03 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Kanchan Healthcare Inc | 85742-023 | 85742-0023-2285742-0023-23 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4257 | 70518-4257-00 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | Major Pharmaceuticals | 0904-7494 | 00904-7494-06 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 59651-505 | 59651-0505-0159651-0505-30 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | 71335-2411 | 71335-2411-0171335-2411-02 |
| Ramelteon | Ramelteon 8 mg/1 | Tablet, Film coatedOral | Asclemed USA, Inc. | 76420-880 | 76420-0880-0176420-0880-3076420-0880-60+1 more |
Other NDCs under ANDA 215243
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | AvPAK | 50268-822 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2310 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0593 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | Sportpharm LLC | 85766-251 |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | ASCLEMED USA INC. | 87063-189 |